KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · IEX Real-Time Price · USD
14.20
-0.77 (-5.14%)
Jul 18, 2024, 4:00 PM EDT - Market closed

KalVista Pharmaceuticals Market Cap

KalVista Pharmaceuticals has a market cap or net worth of $606.85 million as of July 18, 2024. Its market cap has increased by 96.45% in one year.

Market Cap
606.85M
Enterprise Value
405.45M
1-Year Change
96.45%
Ranking
Category
Stock Price
$14.20

Market Cap Chart

Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $606.85M, an increase of 369.33%. That is a compound annual growth rate of 18.13%.

History

DateMarket Cap% Change
Jul 17, 2024639.80M51.15%
Dec 29, 2023423.30M154.39%
Dec 30, 2022166.40M-48.59%
Dec 31, 2021323.70M-4.99%
Dec 31, 2020340.70M7.27%
Dec 31, 2019317.60M-6.64%
Dec 31, 2018340.20M223.69%
Dec 29, 2017105.10M690.23%
Dec 30, 201613.30M-86.04%
Dec 31, 201595.30M-26.30%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Verve Therapeutics 659.97M
Entrada Therapeutics 659.36M
Celcuity 656.04M
Adaptive Biotechnologies 655.79M
Fulgent Genetics 654.44M
Annexon 651.46M
Astria Therapeutics 650.17M
Cassava Sciences 649.12M
Market Cap Rankings